Skip to main content

Table 3 Treatment and Outcome

From: Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series

Directed therapy (N = 32, 78.0%)

 

Long-acting inhaler, N (%)

27 (84.4)

Systemic corticosteroids, N (%)

10 (31.3)

Macrolides, N (%)

18 (56.3)

Oxygen supplementation at rest

Less than or equal to 3 L O2, N (%)

4 (12.5)

Greater than 3 L, N (%)

1 (3.1)

Transplantation, N (%)

1 (3.1)

Mortality, N (%)

11 (26.8)

Time from OB diagnosis to death, months (mean ± SD)

54 ± 53